Navigation Links
Avaxia Biologics Awarded $1.5 Million Phase II SBIR Grant from NIH to Develop Oral Antibody Therapeutic for Inflammatory Bowel Disease
Date:3/19/2012

LEXINGTON, Mass., March 19, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease.  Avaxia Biologics has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to support the development of a novel antibody therapeutic for inflammatory bowel disease. This Phase II award provides Avaxia with $1.5 million in funding over 2 years and was based on the successful completion of a Phase I SBIR award that demonstrated efficacy of AVX-470 in mouse model systems of inflammatory bowel disease.

"We are delighted to have been awarded this grant from the NIH, and we thank the NIH for funding the further safety and efficacy testing of AVX-470 that will pave the way towards clinical trials," said Barbara S. Fox, Avaxia's founder and CEO.  "Our in vivo animal data, generated under prior funding of the NIH, has shown that our orally active anti-TNF antibody significantly reduced inflammatory bowel disease severity in three different animal models and showed superior efficacy to an oral steroid drug in a comparative test of disease remission. 

"We believe these consistent and statistically significant results in the standard animal models of IBD indicate that AVX-470 has the potential to become a leading therapy for inflammatory bowel disease, a chronic and debilitating disease of over a million and a half North Americans and four million people worldwide.  We are also heartened to observe that our product has shown superior efficacy to an oral steroid drug in a comparative test of disease remission.
'/>"/>

SOURCE Avaxia Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Avaxia Biologics Barbara Fox Named one of Mass High Techs Women to Watch in 2012
2. Avaxia Biologics, Inc. Awarded BARDA Contract for Therapeutic Countermeasure to Help the Nation Respond to a Radiological Emergency
3. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease
4. Avaxia Biologics, Inc. to Present Key Pre-Clinical Inflammatory Bowel Disease Remission Data at Biotech Showcase 2011
5. Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Companys Synthetic Biologics Strategic Focus
6. Sumagen Initiates Clinical Testing of Omnia Biologics Manufactured HIV Vaccine
7. Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development
8. BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility
9. Treatment of Patients With Malignant Mesothelioma Utilizing Photodynamic Therapy With Pinnacle Biologics Compound PHOTOFRIN® - Obtains FDA Orphan Drug Designation
10. ResearchMoz: Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)
11. US Biologics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Cephasonics, ... platform, today announced the introduction of the ... complete network-based communications with all cQuest Ultrasound™ ... embedded-ultrasound technology, including this new capability, at ... Paulo, Brazil from May 21-24.  ...
(Date:5/21/2013)... 2013 iHealth Lab Inc., a pioneer ... healthcare products and a powerful integrated mobile app ... of two new fitness products to its existing ... the Wireless Pulse Oximeter and Wireless Activity and ... iHealth Lab is also excited ...
(Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... Cardica, Inc. (Nasdaq: CRDC ) ... General Surgery at the Red Cross Hospital Clementinenhaus, ... laparoscopic procedures using Cardica,s, proprietary Microcutter XPRESS™ 30 ... several sigmoidectomies, an appendectomy and a small intestinal ...
... , For the fourth year, the Fondation,Médéric ... for evidence-based psychosocial,interventions for people with dementia and their ... care and share best,practices. Applications can be submitted from ... http://www.alz.co.uk/award . Psychosocial research involves or ...
Cached Medicine Technology:Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 2Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 34th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia Care 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 Everspark Interactive, ... firms, has been growing rapidly over the past year ... was hired to spearhead interactive marketing efforts for Kids ... , Everspark started as a local effort, specializing ... guiding search traffic to a company's website. The company ...
(Date:5/21/2013)... May 21, 2013 Romio , ... with trusted services & businesses, announced today that it ... Medical Care. , Emergency Medical Care is located in ... 24 hours a day. The guarantee of seeing ... a promising resource for the neighborhood and a great ...
(Date:5/21/2013)... Alan Mozes HealthDay Reporter , , MONDAY, ... used by millions of people with chronic obstructive ... cardiovascular complications among older patients, a new large ... patients over age 65 who are prescribed long-acting ... beta-agonists (such as Serevent). Both medications are commonly ...
(Date:5/21/2013)... effects of poorly controlled asthma symptoms on sleep ... been confirmed in a new study. , ... and school absences are important indicators of asthma ... to explore the associations between asthma, sleep quality, ... using both objective and subjective measures," said principal ...
(Date:5/21/2013)... After the success of its inaugural 1,000 lb. Meltdown ... Boot Camp Goderich will be hosting its 2nd Annual 1,000 ... fitness center located at 199 Anglesea Street Goderich, Ontario. ... is to inspire and motivate local community residents to lose ... fee to participate is discounted to $40 for the 28-day ...
Breaking Medicine News(10 mins):Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:Romio Announces Mini Video Series Featuring Local Business Emergency Medical Care 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3Health News:Asthma symptoms impair sleep quality and school performance in children 2Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3
... (BRONX, NY) Researchers at the Albert Einstein College ... first time that cancers can be successfully treated by ... published in the October 31 issue of PloS One, ... virus-infected cells before they turn cancerous. , The Einstein ...
... BioMed Realty Trust, Inc.,(NYSE: BMR ) today announced ... 30, 2007 after the market closes on Wednesday, November ... Officer, and Kent Griffin,Chief Financial Officer, will host an ... November 8, 2007 to discuss the company,s,financial results and ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today ... conferences during which Mike Grey, president & chief,executive officer ... Company,s oncology pipeline. The conference information is as,follows: ... at 9:00 AM Pacific Daylight ...
... 30 PharmAthene, Inc., a leading,biodefense company specializing ... chemical and biological terrorism,announced today that it is ... /,Acumen BioFin 9th Annual Healthcare Conference on Tuesday, ... for the Company will be David P.,Wright, President ...
... LOS ANGELES Healthcare providers have observed it for years ... life while battling their cancer live longer. Now, a ... with locally advanced non-small cell lung backs that observation. ... other classic predictors of survival. , In the past, weve ...
... Virus Shows Promise as Metastatic Cancer Treatment , ... and can differentiate between normal and cancerous cells. The ... cancers, such as small-cell lung cancer. , Cancer-killing viruses ... therapies for localized cancer. But so far their success ...
Cached Medicine News:Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 2Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 3Health News:BioMed Realty Trust to Report 2007 Third Quarter Results 2Health News:SGX Pharmaceuticals to Present at Three Upcoming Investor Conferences 2Health News:Quality of life: most important predictor of survival for advanced NSCLC patients 2Health News:Other highlights in the Oct. 30 JNCI 2Health News:Other highlights in the Oct. 30 JNCI 3Health News:Other highlights in the Oct. 30 JNCI 4
Long-Sleeve Bolero for targeted compression in the upper arms, upper back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Velcro® closure, uniform contour compression, available as 9" and 12" bands for abdominal support, 9" can be used as a breast wrap....
Sub Pectoral Breast Augmentation Wrap...
CDIs Ultra-Comfort Bra™ is designed with special single needle stitching that places the cup seams away from critical surgical sites....
Medicine Products: